Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H23N3O4 |
| Molecular Weight | 309.3608 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COCCCNC(=O)C1=CC=NC(=C1)C(=O)NCCCOC
InChI
InChIKey=HLSXICGBWKECLM-UHFFFAOYSA-N
InChI=1S/C15H23N3O4/c1-21-9-3-6-17-14(19)12-5-8-16-13(11-12)15(20)18-7-4-10-22-2/h5,8,11H,3-4,6-7,9-10H2,1-2H3,(H,17,19)(H,18,20)
Aventis developed safironil as a competitive inhibitor of collagen protein synthesis for the treatment of liver disorders. This compound participated in phase I clinical trial for the treatment of cirrhosis in Germany. In addition, it was studied for hepatic fibrosis treatment. However, information about the further development of this compound is not available.
Originator
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60158677
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
134377-69-8
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
C109927
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
CK4M8AX1LN
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
7018
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
SUB10413MIG
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105464
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
100000084372
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
65973
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY | |||
|
C74278
Created by
admin on Wed Apr 02 08:44:27 GMT 2025 , Edited by admin on Wed Apr 02 08:44:27 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
